Baptist Health Cancer Care is the largest cancer care program in South Florida, comprised of a unified two-institute model, Miami Cancer Institute and Lynn Cancer Institute. Across 15 locations spanning from Key West to Palm Beach County, the program delivers comprehensive oncology services close to home for patients throughout the region. In FY24, Baptist Health Cancer Care treated approximately 18,000 new cancer cases and was ranked the second-largest cancer program in Florida by Florida Trend.
Across both institutes, patients benefit from advanced multidisciplinary expertise in medical oncology, radiation oncology, surgical oncology, cellular therapy, and comprehensive support services. This year, the program will expand proton therapy capabilities with a second proton modality at Lynn Cancer Institute, bringing highly precise radiation treatment to patients in Palm Beach County.
Miami Cancer Institute continues to operates at significant scale, with more than half a million patient encounters and over 23,000 procedures since the start of FY25. Its advanced radiation technologies, including Gamma Knife, MR Linac, and Zap X, remain key differentiators, with nearly 1,800 highly specialized treatments delivered. The FACT reaccreditation of the Blood and Marrow Transplant program reinforces national leadership in cellular therapy.
Lynn Cancer Institute complements this strength with a perfect score Commission on Cancer reaccreditation, NAPBC accreditation, QOPI-certified infusion services, and impactful research across breast, lung, gastrointestinal, hematologic, and immunotherapy disciplines.
In 2027, we plan to open our doors to the Al & Jane Nahmad Women’s Cancer Center, to provide quality cancer care to women in South Florida. This will be the first building of it’s kind available to patients in the Southeast region.
Through artificial intelligence–enhanced screening, including AI-supported mammography, continued geographic expansion into communities such as Key West and Doral, rising patient and employee satisfaction, and a robust clinical research portfolio, Baptist Health Cancer Care continues to advance innovation, expand access and redefine world-class cancer care across South Florida
Young Women & Breast Cancer: Understanding Early-Onset Risk, Genetics & Fertility
In this episode of Baptist Health’s Doc-to-Doc, we take a closer look at one of the most concerning trends in oncology — the rise of breast cancer among younger women.
Advancing the Standard: Gynecologic Cancer Care
In this episode of Doc to Doc, Dr. Thomas Morrissey, director of gynecologic oncology at Lynn Cancer Institute, joins Dr. Ryan Kahn, gynecologic oncologist at Miami Cancer Institute, to explore how data from pivotal studies like TRUST, ...
Musculoskeletal Interventions in Oncology: Creating New Options
Interventional radiology (IR) has emerged as a transformative force in musculoskeletal oncology, significantly impacting the clinical management of bone and soft tissue tumors.
A Pioneer’s Approach to Rectal Spacers for Prostate Cancer Treatment
Marcio Fagundes, M.D., is emerging as a transformative voice in radiation oncology, pioneering the use of rectal spacers to shield the rectum from potential radiation damage during the treatment of prostate cancer.
Lung Cancer Treatment Evolutions Include Surgical Innovation and Molecular Targeted Therapy
Lung cancer survival rates have approximately doubled over the past two decades — a remarkable achievement driven by convergent advances in early detection, surgical technique and molecular oncology.
Expanding Treatment Options for Brain Metastases in NSCLC
Brain metastases in non-small cell lung cancer (NSCLC) have historically presented significant treatment challenges with limited options
Physicians grappling with uncertainty about artificial intelligence’s role in medicine need look no further than breast radiologist Kathy Schilling, M.D., FACR, for guidance
Advancing Clinical Oncology: Research Highlights from Baptist Health South Florida
Across Baptist Health South Florida, physician-researchers are leading studies that not only generate novel insights but also accelerate the translation of innovation into clinical protocols.
Lymphoma: CAR T Treatment Safe and Effective for Outpatients in Proper Settings
A study led by Baptist Health Miami Cancer Institute supports emerging scientific evidence that complex immunotherapy treatment can be safely provided on an outpatient basis instead of requiring a hospital stay — at specialized, community-based centers.
Researchers at Miami Cancer Institute, part of Baptist Health Cancer Care, and published in Cancers, offers the first direct comparison of ablative five-fraction stereotactic magnetic resonance-guided online adaptive radiation therapy ...
Brain Tumors: Shining Light on the Latest Advances
The human brain — and its 86 billion neurons — controls complex movements, stores and receives memories, generates emotions and runs all of the body’s automatic functions simultaneously.
A Powerful Team Researches Re-irradiation Options for Breast Cancer Recurrence
When breast cancer returns in a previously treated breast, the standard approach has been salvage mastectomy. The recently launched BRASIL trial (NCT06867484) aims to challenge this paradigm by investigating whether carefully selected ...
Combining magnetic resonance (MR)-guided focused ultrasound with microbubbles and immune checkpoint inhibitors (ICIs) could transform non-small cell lung cancer (NSCLC) treatment by reducing radiation side effects.